SALVACAN P
SALVACAN P
Authorised
- Immunoglobulins against Canine parvovirus, Canine
Product identification
Medicine name:
SALVACAN P
Active substance:
- Immunoglobulins against Canine parvovirus, Canine
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Immunoglobulins against Canine parvovirus, Canine1024.00/haemagglutination inhibiting unit(s)1.00Dose
Pharmaceutical form:
-
Lyophilisate for solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
-
Intramuscular use
- Dog
-
Intravenous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA01
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Romvac Company S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Romvac Company S.A.
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 120116
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 17/01/2022
How useful was this page?:
